William Poisson
Acute Care · Augusta, GANPI 1447603949
Payments from drug & device makers
Across 67 payments — averaging $22.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$371
- Fresenius USA Marketing, Inc.$211
- Ardelyx, Inc.$136
- Amgen$127
- Vifor Pharma, Inc.$102
- Mallinckrodt Hospital Products Inc.$79
- plus $511 from 15 others
What the payments were for
- Food & beverage$1,51899%
- Education$181%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 14 | $371 |
| Fresenius USA Marketing, Inc. | 11 | $211 |
| Ardelyx, Inc. | 3 | $136 |
| Amgen | 5 | $127 |
| Vifor Pharma, Inc. | 5 | $102 |
| Mallinckrodt Hospital Products Inc. | 3 | $79 |
| Otsuka America Pharmaceutical, Inc. | 3 | $76 |
| GSK | 4 | $76 |
| Bayer | 4 | $65 |
| Aurinia Pharma U.S., Inc. | 2 | $40 |
| Lexicon Pharmaceuticals, Inc. | 2 | $35 |
| Boehringer Ingelheim | 2 | $34 |
| Novartis | 1 | $28 |
| Merck | 1 | $26 |
| Calliditas Therapeutics US Inc. | 1 | $24 |
| Renalytix AI, Inc. | 1 | $20 |
| Veloxis Pharmaceuticals, Inc. | 1 | $19 |
| OPKO Pharmaceuticals, LLC | 1 | $18 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $18 |
| Travere Therapeutics, Inc. | 1 | $17 |
| Mylan Specialty L.p. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$124
How this compares
$1,536 in reported general payments places this provider in the 80th percentile of 679 acute care providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sevelamer Carbonate | 28 | $4,233 |
| Nifedipine ErNifedipine | 20 | $684 |
| Hydralazine Hcl | 36 | $561 |
| Bumetanide | 11 | $371 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 21 | $319 |
| Metoprolol Succinate | 21 | $229 |
| Furosemide | 25 | $167 |
| Atorvastatin Calcium | 19 | $162 |
| Carvedilol | 22 | $148 |
| Sertraline Hcl | 23 | $126 |
| Amlodipine Besylate | 26 | $119 |
| ClopidogrelClopidogrel Bisulfate | 11 | $118 |
| Pantoprazole Sodium | 14 | $114 |
| Hydroxyzine Hcl | 13 | $105 |
| Losartan Potassium | 13 | $41 |
Paid to pharmacies, not to this prescriber.
Other acute care in Augusta
- Erin CooperAugusta$5K
- Darryl TurnerRinggold$21K
- Bryce CowgillCumming$16K
- Stacy CreelSavannah$15K
- Susan BeitzellAthens$13K
- Crystal KuhnCumming$12K
- Mark ClarkGainesville$10K
- Sarah WymanAtlanta$10K
- Jeffrey DillerAustell$10K
- Ayeshia PowellAtlanta$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.